354Tip A Phase III Randomised Open-Label Study of Extended Adjuvant Therapy with Camizestrant Vs Standard Endocrine Therapy (ET) in Patients with ER+/HER2– Early Breast Cancer (BC) and an Intermediate or High Risk of Recurrence (CAMBRIA-1)
CANCER RESEARCH（2024）
关键词
Neoadjuvant Therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要